8-K/A

FORM 8-K AMENDMENT NO 1

Company: Marker Therapeutics, Inc.
Filed: January 29, 2016
Period of Report: January 26, 2016
Accession Number: 0001193125-16-442180

View Document ↗ View on SEC.gov ↗